Veterinary Medicines

PULSIX 40 mg/200 mg spot-on solution for dogs over 1.5 kg up to 4 kg

Authorised
  • Imidacloprid
  • Permethrin (40:60)
Download as PDF

Product identification

Medicine name:
PULSIX 40 mg/200 mg spot-on solution for dogs over 1.5 kg up to 4 kg
Pulsix (40 mg + 200 mg)/pipetkę 0,4 ml Roztwór do nakrapiania
Active substance:
  • Imidacloprid
  • Permethrin (40:60)
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin (40:60)
    200.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • Cardboard box containing 1 pipette of 0.4 ml with pouch
  • Cardboard box containing 1 pipette of 0.4 ml without pouch
  • Cardboard box containing 2 pipettes of 0.4 ml with pouch
  • Cardboard box containing 2 pipettes of 0.4 ml without pouch
  • Cardboard box containing 3 pipettes of 0.4 ml without pouch
  • Cardboard box containing 4 pipettes of 0.4 ml with pouch
  • Cardboard box containing 4 pipettes of 0.4 ml without pouch
  • Cardboard box containing 6 pipettes of 0.4 ml with pouch
  • Cardboard box containing 6 pipettes of 0.4 ml without pouch
  • Cardboard box containing 24 pipettes of 0.4 ml with pouch
  • Cardboard box containing 24 pipettes of 0.4 ml without pouch
  • Cardboard box containing 3 pipettes of 0.4 ml with pouch
  • Cardboard box containing 12 pipettes of 0.4 ml without pouch
  • Cardboard box containing 12 pipettes of 0.4 ml with pouch

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ab7 Sante
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ab7 Sante
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 3378
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0667/001
Concerned member states:
  • France
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Spain
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."